BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30558719)

  • 1. Current Approaches to Pancreatic Cancer Screening.
    Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
    Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.
    Becker AE; Hernandez YG; Frucht H; Lucas AL
    World J Gastroenterol; 2014 Aug; 20(32):11182-98. PubMed ID: 25170203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Pancreatic Ductal Adenocarcinoma.
    Diaz KE; Lucas AL
    Am J Pathol; 2019 Jan; 189(1):36-43. PubMed ID: 30558720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Pancreatic Cancer and the Future of Directed Screening.
    Welinsky S; Lucas AL
    Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial pancreatic cancer.
    Rieder H; Bartsch DK
    Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancreatic cancer-screening or surveillance?].
    Sirtl S; Vornhülz M; Hofmann FO; Mayerle J; Beyer G
    Radiologie (Heidelb); 2023 Dec; 63(12):908-915. PubMed ID: 37878016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable Gastrointestinal Cancer Syndromes.
    Stoffel EM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Management of Hereditary Pancreatic Cancer.
    Humphris JL; Biankin AV
    Recent Results Cancer Res; 2016; 205():61-83. PubMed ID: 27075349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited predisposition to pancreatic cancer.
    Hilfrank KJ; Rustgi SD; Kastrinos F
    Semin Oncol; 2021 Feb; 48(1):2-9. PubMed ID: 33773812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and carcinogenesis of pancreatic ductal adenocarcinoma].
    Song SY
    Korean J Gastroenterol; 2008 Feb; 51(2):71-83. PubMed ID: 18349569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines.
    Bennett C; Suguitan M; Abad J; Chawla A
    Pancreatology; 2022 Sep; 22(6):719-729. PubMed ID: 35798629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
    DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
    Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Pancreatic Cancer in High-risk Populations.
    Grover S; Jajoo K
    Gastroenterol Clin North Am; 2016 Mar; 45(1):117-27. PubMed ID: 26895684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.